CRYO CELL INTERNATIONAL INC

For the period ended Feb 28, 2025. Filed Apr 14, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Feb 28, 2025 · Filed Apr 14, 2025

CCEL$4.87-0.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Stockholders’ Deficit

Additional · Total
Common Stock · Paid-In · Treasury · Accumulated · Stockholders'
Shares · Amount · Capital · Stock · Deficit · Deficit
Balance at November 30, 2024	14,849,619	$148,696	$44,268,469	$(24,855,556)	$(32,777,626)	$(13,216,017)
Compensatory element of stock options			297,392				297,392
Dividends declared ($0.25 per share)					(2,020,539)		(2,020,539)
Net income					282,855		282,855
Balance at February 28, 2025	14,849,619	$148,696	$44,565,861	$(24,855,556)	$(34,515,310)	$(14,656,309)
Additional · Total
Common Stock · Paid-In · Treasury · Accumulated · Stockholders'
Shares · Amount · Capital · Stock · Deficit · Deficit
Balance at November 30, 2023	14,849,246	$148,492	$43,411,143	$(23,431,685)	$(31,159,182)	$(11,031,232)
Compensatory element of stock options			307,355				307,355
Treasury stock				(170,376)			(170,376)
Net income					556,241		556,241
Balance at February 29, 2024	14,849,246	$148,492	$43,718,498	$(23,602,061)	$(30,602,941)	$(10,338,012)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.